Zhendong Chen

3.7k citations
54 papers · 1.0k indexed · 1 hit paper · h-index 17
Topics
Cancer Immunotherapy and Biomarkers (15 papers)Pancreatic and Hepatic Oncology Research (9 papers)Colorectal Cancer Treatments and Studies (9 papers)
Journals
Nature CommunicationsJournal of Clinical OncologySHILAP Revista de lepidopterología
Partner nations
ChinaUnited StatesTaiwan

In The Last Decade

Zhendong Chen

51 papers receiving 1.0k citations

Hit Papers

Pembrolizumab Versus Placebo as Second-Line Therapy in Pa...202220262023202420224080120

Peers

Zhendong Chen
Comparison fields: 5 of 75
  • Oncology 521
  • Pulmonary and Respiratory Medicine 357
  • Hepatology 286
  • Radiology, Nuclear Medicine and Imaging 194
  • Surgery 153
Replace Steven Blotner with:
Steven Blotner United States
Sang Soo Kim South Korea
Tomoki Kubota Japan
Diana L. Hanna United States
Tamito Sasaki Japan
Yukio Iwashita Japan
Takahiro Einama Japan
Shisuo Du China
Feng Han China
Koji Miyahara Japan
Zhendong Chen relative to Steven Blotner United States Steven Blotner's profile →
Citations per field
00.5×1.5×2.4×
Steven Blotner · 1×
Citations per year

Countries citing papers authored by Zhendong Chen

Since Specialization
Citations

This map shows the geographic impact of Zhendong Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhendong Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhendong Chen more than expected).

Fields of papers citing papers by Zhendong Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhendong Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhendong Chen. The network helps show where Zhendong Chen may publish in the future.

Co-authorship network of co-authors of Zhendong Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Zhendong Chen. A scholar is included among the top collaborators of Zhendong Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhendong Chen. Zhendong Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 2
2 16
3 2
4 1
5 3
6 0
7 1
8 1
9
Pembrolizumab Versus Placebo as Second-Line Therapy in Patients From Asia With Advanced Hepatocellular Carcinoma: A Randomized, Double-Blind, Phase III Trialbreakdown →
127
10 3
11 38
12 4
13 61
14 2
15 32
16 68
17 8
18 20
19 2
20 11

About Zhendong Chen

Zhendong Chen is a scholar working on Oncology, Hepatology and Pulmonary and Respiratory Medicine, having authored 54 papers that have together received 1.0k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (15 papers), Pancreatic and Hepatic Oncology Research (9 papers) and Colorectal Cancer Treatments and Studies (9 papers). The work is most often cited by research in Hepatology (286 citations), Oncology (521 citations) and Pulmonary and Respiratory Medicine (357 citations). Zhendong Chen has collaborated with scholars based in China, United States and Taiwan. Frequent co-authors include Yuxian Bai, Shukui Qin, Zhenggang Ren, Zhiqiang Meng, Jianjun Zou, Xiaohong Chen, Weijia Fang, Jianping Xiong, Linna Wang and Mengjie Fang. Their work appears in journals such as Nature Communications, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026